Passive Sensor Identification of Digital Biomarkers to Assess Effects of Orally Administered Nicotinamide Riboside

Abroad (travel likely)Recruiting

Conditions

Alzheimer Disease · Dementia Alzheimers · Dementia · Cognitive Impairment · Mild Cognitive Impairment · Neurodegenerative Diseases · Neurocognitive Disorders · Neurocognitive Dysfunction · Cognitive Dysfunction · Mental Disorder

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

McLean Hospital, Belmont, Massachusetts, United States
Contact: Study coordinator (Edward de la Cruz, BA) · edelacruz@mgb.org · 617-855-2489
Contact: Study coordinator (Kimaya Reddy, BA) · kareddy@mclean.harvard.edu · 617-855-3136

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Comprehensive Assessment of Neurodegeneration and Dementia

Dementia · Mild Cognitive Impairment (MCI) · Subjective Cognitive Impairment

Abroad (travel likely)Recruiting

Calgary, Canada · Edmonton, Canada

TREAD: Time Restricted Eating Intervention for Alzheimer's Disease

Mild Cognitive Impairment · Alzheimer Disease · Alzheimer's Disease

Abroad (travel likely)RecruitingPHASE1

San Diego, United States

Dementia Caregivers' Link to Assistance and Resources

Alzheimer Disease or Associated Disorder · Dementia

Abroad (travel likely)Recruiting

New York, United States

Longitudinal Early-onset Alzheimer's Disease Study Protocol

Early Onset Alzheimer Disease · Alzheimer Disease · Mild Cognitive Impairment

Abroad (travel likely)Recruiting

Sun City, United States · Los Angeles, United States